Impact of COVID-19 Response on Hepatitis Prevention Care and Treatment: Results From Global Survey of Providers and Program Managers.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

18 citing papers in PubMed.

1. Impact of the COVID-19 pandemic on hepatitis C care across the cascade of care: a scoping review.BMC infectious diseases · 2026
   Article
2. Impact of COVID-19 Pandemic on Testing for Hepatitis B in British Columbia, Canada: An Interrupted Time Series Analysis.Open forum infectious diseases · 2025
   Article
3. The Efficacy of Glecaprevir/Pibrentasvir in Chronic Hepatitis C Patients and the Impact of the COVID-19 Pandemic: Multicenter Real-Life Data.Infectious diseases & clinical microbiology · 2024
   Article
4. The COVID-19 Pandemic Affected Hepatitis C Virus Circulation and Genotypic Frequencies-Implications for Hepatitis C Prevention, Treatment and Research.Epidemiologia (Basel, Switzerland) · 2024
   Article
5. Global Perspectives on the Hepatitis B Vaccination: Challenges, Achievements, and the Road to Elimination by 2030.Vaccines · 2024
   Review
6. Public healthcare system utilization for chronic hepatitis C infection in Vietnam.BMC infectious diseases · 2023
   Article
7. The impact of COVID-19 on hepatitis B and C virus prevention, diagnosis, and treatment in Bangladesh compared with Japan and the global perspective.BMC health services research · 2023
   Article
8. Impact of COVID-19 Pandemic on Seroprevalence of HIV, HBV, HCV and HTLV I-II in a Blood Bank in Medellín, Colombia, 2019-2022.Tropical medicine and infectious disease · 2023
   Article
9. Additional challenges in reaching hepatitis C elimination goals in Germany due to the COVID-19 pandemic - descriptive analysis of drug prescription data from January 2018 to June 2021.Frontiers in public health · 2023
   Article
10. Falling treatment uptake in the hepatitis C care cascade is a growing threat to achieving elimination.Journal of viral hepatitis · 2023
    Article
11. Impact of the COVID-19 pandemic on hepatitis B and C elimination: An EASL survey.JHEP reports : innovation in hepatology · 2022
    Article
12. Costs and health impact of delayed implementation of a national hepatitis B treatment program in China.Journal of global health · 2022
    Article
13. Impact of COVID-19 pandemic on HCV care cascade in Rwanda: Ecological study from July 2019 to June 2021.Clinical liver disease · 2022
    Article
14. The Importance of Prisons in Achieving Hepatitis C Elimination: Insights from the Australian Experience.Viruses · 2022
    Article
15. Regional progress towards hepatitis C elimination in the Western Pacific Region, 2015-2020.Global health & medicine · 2021
    Review
16. Erratum.Clinical liver disease · 2021
    Article
17. Utilizing Telemedicine and Modified Fibrosis Staging Protocols to Maintain Treatment Initiation and Adherence Among Hepatitis C Patients During the COVID-19 Pandemic.Journal of primary care & community health
    Article
18. Barriers to longitudinal follow-up for hepatitis B treatment in rural Sierra Leone: A mixed methods study of retention in care.Clinical liver disease
    Article

Corrections and comments

• Erratum issued
  Erratum.2021

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract